Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Xenofon Baraliakos¹, Joachim Listing², Jan Brandt¹, Angela Zink², Rieke Alten³, Gerd Burmester⁴, Erika Gromnica-Ihle⁵, Herbert Kellner⁶, Matthias Schneider⁷, Helmut Sörensen⁸, Hennig Zeidler⁹, Martin Rudwaleit¹⁰, Joachim Sieper¹⁰ and Juergen Braun¹

¹Rheumazentrum Ruhrgebiet, Herne, Ruhr University Bochum, Germany

²German Rheumatism Research Center, Berlin, Germany

³Schlosspark Clinic, Berlin, Germany

⁴Charité, University Medicine Berlin, Campus Mitte, Germany

⁵Berlin-Buch Hospital, Berlin, Germany

⁶Ludwig-Maximilians-University, Munich, Germany

⁷Heinrich-Heine-University, Düsseldorf, Germany

⁸Private Praxis, Berlin, Germany

⁹Medical University of Hannover, Hanover, Germany

¹⁰Charité, Medical University of Berlin, Campus Benjamin Franklin, Department of Rheumatology, Germany

author email corresponding author email

Arthritis Research & Therapy 2005, 7:113doi:10.1186/ar1750

Published:

23 March 2005

Correction

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been added and the Authors' contributions and Competing interests section modified accordingly.

Competing interests

Dr Braun and Dr Sieper have held consultancies and received research honoraria, speaker's honoraria and grants/research support from Centocor, Schering-Plough, Essex Pharma, Wyeth and Abbott. Dr Zeidler has received speaker's honoraria from Essex Pharma. Dr Burmester has held consultancies for Centocor, Essex Pharma, Wyeth and Abbott; has received honoraria from Centocor, Essex Pharma, Wyeth and Abbott; has been a member of a speaker's bureau for Centocor, Essex Pharma, Wyeth and Abbott; and has received grants/research support from Centocor, Essex Pharma and Abbott. The other authors declare no conflicts of interest.

Authors' contributions

XB: Preparation of data analysis, preparation of the manuscript and study coordination; JL, AZ: Data analysis and statistical evaluation; JB, MR: Monitoring and investigation of the patients and study coordination; RA, GB, EG-I, HK, MS, HS, HZ: clinical investigation; JS: Investigator, writing of the manuscript; JB: Idea, writing of the manuscript, prinicipal investigator and responsible for the study.

References

Baraliakos X, Listing J, Brandt J, Rudwaleit M, Sieper , Braun J: Clinical response to withdrawal of anti-TNF therapy in patients with ankylosing spondylitis (AS) after 3 years of continuous treatment with Infliximab.
Arthritis Res Ther 2005, 7:R439-R444. PubMed Abstract | BioMed Central Full Text

Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Correction

Competing interests

Authors' contributions

References

Have something to say? Post a comment on this article!